ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Gross Margin history
Percent of revenue · from the income statement
No Gross Margin data reported for this period type.
Gross Margin vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| FY2025 | 100.0% | — | — | |
| LTM Mar 2026 | 93.8% | -4.1 pp | -20.7 pp | |
| LTM Mar 2026 | 91.6% | +64.6 pp | -6.0 pp | |
| LTM Mar 2026 | 91.2% | -8.8 pp | -4.5 pp | |
| LTM Mar 2026 | 90.4% | -9.1 pp | +0.0 pp | |
| LTM Mar 2026 | 89.7% | -10.3 pp | -17.0 pp | |
| LTM Mar 2026 | 66.4% | — | +23.7 pp | |
| LTM Mar 2026 | -1082.7% | -1182.7 pp | — | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ADRX) | 90.8% | -8.9 pp | -5.2 pp | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.